Sign In
Buy ADMA
$8.69
+0.120 (+1.40%)
At Close: Jun 23, 2026
Block & Leviton is investigating ADMA Biologics for potential securities fraud. Investors who lost money in ADMA should contact the firm to learn more.
ADMA Biologics, Inc. (ADMA) Q4 2024 Earnings Call Transcript
06:24pm, Monday, 03'rd Mar 2025
ADMA Biologics, Inc. (NASDAQ:ADMA ) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ET Company Participants Skyler Bloom - Senior Director, Business Development and Corporate Strategy Adam Gros
ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
04:05pm, Monday, 03'rd Mar 2025
FY 2024 Total Revenue of $426.5 Million, a 65% YoY Increase FY 2024 GAAP Net Income of $197.7 Million, Including an $84.3 Million Valuation Allowance Tax Benefit FY 2024 Adjusted EBITDA (1) of $164.6
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
07:00am, Friday, 28'th Feb 2025
RAMSEY, N.J. and BOCA RATON, Fla., Feb. 28, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated
Wall Street Analysts Look Bullish on Adma Biologics (ADMA): Should You Buy?
10:35am, Tuesday, 25'th Feb 2025
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
07:00am, Tuesday, 25'th Feb 2025
RAMSEY, N.J. and BOCA RATON, Fla.
Adma Biologics (ADMA) Stock Slides as Market Rises: Facts to Know Before You Trade
06:51pm, Wednesday, 19'th Feb 2025
Adma Biologics (ADMA) closed the most recent trading day at $16.07, moving -0.62% from the previous trading session.
Pharma Stock Poised to Bounce Off Support
01:10pm, Wednesday, 12'th Feb 2025
Pharmaceutical concern ADMA Biologics Inc (NASDAQ:ADMA) has been consolidating above familiar pressure at the $16 region since mid-January.
ADMA Loses 8.9% in a Month: How Should You Play the Stock?
02:46pm, Friday, 07'th Feb 2025
ADMA Biologics' shares lose 8.9% in a month after putting up a phenomenal performance in the past 12 months. While the prospects remain sound, the exceptional rally witnessed by the stock might limit
Adma Biologics (ADMA) Advances But Underperforms Market: Key Facts
06:50pm, Thursday, 06'th Feb 2025
In the closing of the recent trading day, Adma Biologics (ADMA) stood at $16.92, denoting a +0.3% change from the preceding trading day.
ADMA Biologics: Recent Pullback Is A Perfect Opportunity To Add
01:46pm, Thursday, 06'th Feb 2025
ADMA Biologics specializes in primary immune deficiencies with Asceniv, a high-margin, unique product that outperforms competitors and has significant growth potential in the U.S. market. Asceniv's hi
Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note
06:56pm, Monday, 03'rd Feb 2025
Adma Biologics (ADMA) concluded the recent trading session at $16.47, signifying a +1.98% move from its prior day's close.
Adma Biologics (ADMA) Stock Declines While Market Improves: Some Information for Investors
06:56pm, Tuesday, 28'th Jan 2025
Adma Biologics (ADMA) closed the most recent trading day at $16.17, moving -0.12% from the previous trading session.
Adma Biologics (ADMA) Rises Higher Than Market: Key Facts
06:56pm, Wednesday, 22'nd Jan 2025
Adma Biologics (ADMA) concluded the recent trading session at $16.47, signifying a +1.92% move from its prior day's close.
There May Still Be Time to Get in on These 3 Trending Biotechs
08:15am, Monday, 20'th Jan 2025
Despite the strength of the economy overall, 2024 was a challenging year for the biotech industry. The high cost of borrowing—particularly prior to the Fed's first rate cut in several years in Septe
